Online Press Release Distribution | EON: Enhanced Online News

Welcome

EON: Enhanced Online News

Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapsing-Remitting Multiple Sclerosis

May 24, 2010 08:33 AM Eastern Daylight Time

Opens in new window

Download

Thumbnail JPEG, 120x53,
Preview JPEG, 144x64,
Small JPEG, 300x134,
Full Size JPEG, 946x424,

Smart Multimedia Gallery

http://eon.businesswire.com/multimedia/eon/20100524005548/en/2018305/Abbott/Biogen-Idec/Daclizumab

View and Share Logo

http://eon.businesswire.com/multimedia/eon/20100524005548/en/2018306/Abbott/Biogen-Idec/Daclizumab

Share

Email

News > News Release: Biogen Idec and Abbott Announce Enrollment of F...